Natera Debt to Equity Ratio 2014-2025 | NTRA
Current and historical debt to equity ratio values for Natera (NTRA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Natera debt/equity for the three months ending March 31, 2025 was 0.00.
| Natera Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.49B | $1.24B | 0.40 |
| 2024-12-31 | $0.47B | $1.20B | 0.39 |
| 2024-09-30 | $0.71B | $0.88B | 0.81 |
| 2024-06-30 | $0.68B | $0.84B | 0.81 |
| 2024-03-31 | $0.67B | $0.79B | 0.85 |
| 2023-12-31 | $0.68B | $0.77B | 0.88 |
| 2023-09-30 | $0.66B | $0.79B | 0.84 |
| 2023-06-30 | $0.65B | $0.60B | 1.09 |
| 2023-03-31 | $0.67B | $0.65B | 1.03 |
| 2022-12-31 | $0.69B | $0.71B | 0.98 |
| 2022-09-30 | $0.65B | $0.36B | 1.79 |
| 2022-06-30 | $0.62B | $0.45B | 1.40 |
| 2022-03-31 | $0.60B | $0.54B | 1.11 |
| 2021-12-31 | $0.58B | $0.65B | 0.89 |
| 2021-09-30 | $0.55B | $0.76B | 0.73 |
| 2021-06-30 | $0.55B | $0.30B | 1.84 |
| 2021-03-31 | $0.52B | $0.37B | 1.40 |
| 2020-12-31 | $0.45B | $0.49B | 0.92 |
| 2020-09-30 | $0.44B | $0.54B | 0.82 |
| 2020-06-30 | $0.42B | $0.30B | 1.38 |
| 2020-03-31 | $0.30B | $0.26B | 1.16 |
| 2019-12-31 | $0.30B | $0.28B | 1.09 |
| 2019-09-30 | $0.30B | $0.09B | 3.49 |
| 2019-06-30 | $0.29B | $0.09B | 3.12 |
| 2019-03-31 | $0.26B | $0.01B | 51.44 |
| 2018-12-31 | $0.24B | $0.03B | 7.34 |
| 2018-09-30 | $0.22B | $0.06B | 3.90 |
| 2018-06-30 | $0.22B | $-0.02B | -9.82 |
| 2018-03-31 | $0.22B | $0.00B | -57.41 |
| 2017-12-31 | $0.19B | $0.03B | 7.44 |
| 2017-09-30 | $0.17B | $0.03B | 5.76 |
| 2017-06-30 | $0.11B | $0.05B | 2.11 |
| 2017-03-31 | $0.10B | $0.07B | 1.39 |
| 2016-12-31 | $0.10B | $0.11B | 0.98 |
| 2016-09-30 | $0.10B | $0.14B | 0.73 |
| 2016-06-30 | $0.10B | $0.16B | 0.60 |
| 2016-03-31 | $0.08B | $0.18B | 0.46 |
| 2015-12-31 | $0.08B | $0.19B | 0.44 |
| 2015-09-30 | $0.06B | $0.21B | 0.27 |
| 2015-06-30 | $0.06B | $0.04B | 1.49 |
| 2015-03-31 | $0.00B | $0.00B | 0.00 |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | $0.00B | 0.00 |
| 2014-06-30 | $0.00B | $0.00B | 0.00 |
| 2013-12-31 | $0.05B | $0.01B | 3.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.420B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.561B | 26.74 |
| Elevance Health (ELV) | United States | $88.026B | 11.36 |
| CVS Health (CVS) | United States | $80.784B | 10.04 |
| Cencora (COR) | United States | $55.036B | 19.15 |
| DiDi Global (DIDIY) | China | $23.580B | 35.79 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.007B | 0.00 |
| Solventum (SOLV) | United States | $12.962B | 13.72 |
| CochLear (CHEOY) | Australia | $11.342B | 0.00 |
| ICON (ICLR) | Ireland | $11.283B | 10.49 |
| Revvity (RVTY) | United States | $10.948B | 18.84 |
| Doximity (DOCS) | United States | $10.905B | 50.49 |
| Viatris (VTRS) | United States | $10.340B | 3.55 |
| HealthEquity (HQY) | United States | $9.613B | 42.11 |
| Avantor (AVTR) | United States | $9.165B | 13.32 |
| Medpace Holdings (MEDP) | United States | $8.574B | 22.77 |
| Sonic Healthcare (SKHHY) | Australia | $8.388B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.243B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.238B | 24.96 |
| BrightSpring Health Services (BTSG) | United States | $4.157B | 38.48 |
| Sotera Health (SHC) | United States | $3.508B | 19.93 |
| Surgery Partners (SGRY) | United States | $2.994B | 38.93 |
| Alignment Healthcare (ALHC) | United States | $2.924B | 0.00 |
| Concentras Parent (CON) | United States | $2.830B | 16.36 |
| Organon (OGN) | United States | $2.537B | 2.70 |
| GeneDx Holdings (WGS) | United States | $2.066B | 79.58 |
| Ardent Health Partners (ARDT) | United States | $1.957B | 8.34 |
| Premier (PINC) | United States | $1.900B | 14.43 |
| Progyny (PGNY) | United States | $1.883B | 41.45 |
| PACS (PACS) | United States | $1.586B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.468B | 29.36 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.214B | 9.24 |
| Establishment Labs Holdings (ESTA) | $1.113B | 0.00 | |
| CareDx (CDNA) | United States | $1.098B | 17.15 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.944B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.818B | 7.66 |
| QDM (QDMI) | Hong Kong, SAR China | $0.752B | 0.00 |
| Nutex Health (NUTX) | United States | $0.654B | 9.90 |
| Embecta (EMBC) | United States | $0.579B | 3.90 |
| LifeMD (LFMD) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.546B | 44.92 |
| InnovAge Holding (INNV) | United States | $0.520B | 0.00 |
| SBC Medicals (SBC) | United States | $0.507B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.437B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.244B | 0.00 |
| Oncology Institute (TOI) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.099B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.081B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |